Skip to main content

Advertisement

Log in

Should We Look for Strongyloides Stercoralis in Foreign-Born HIV-Infected Persons?

  • Original Paper
  • Published:
Journal of Immigrant and Minority Health Aims and scope Submit manuscript

Abstract

The objective was to evaluate the implementation of a systematic Strongyloides stercoralis screening programme in HIV infected immigrants attending an HIV Unit in Spain. An enzyme-linked immunosorbent assay (ELISA) was performed to assess the presence of Strongyloides IgG. Patients with a positive serology were treated with ivermectin; serologic follow-up testing was performed. 237 patients were screened (65.4 % men). Origin: 64.1 % came from Latin America, 16.5 % from Sub-Saharan Africa, 9.7 % from the Caribbean, 9.7 % from other areas. Strongyloides stercolaris IgG was positive in 13 cases (5.5 %). In the multivariate analysis, factors associated with a positive Strongyloides serology were illiteracy (OR: 23.31; p = 0.009) and eosinophilia (OR: 15.44; p < 0.0001). Nine of the 13 patients positive for S. stercoralis IgG and treated with ivermectin had a follow up serologic test: 77.8 % achieved a serologic response (55.5 % seroreversion). Screening of HIV-positive immigrants may be desirable, at least in those with higher risk of hyperinfection syndrome. Serologic testing seems a useful tool in both diagnosis and follow-up of these patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Instituto Nacional de Estadística. Avance del padrón municipal a 1 de enero de 2010. Población por lugar de nacimiento y sexo, 2010.

  2. Centro Nacional de Epidemiología. Vigilancia epidemiológica del VIH en españa. Nuevos diagnósticos de VIH en españa. Periodo 2003–2009.: Sistemas de información sobre nuevos diagnósticos de VIH autonómicos, Actualización 30 de junio de 2010.

  3. Siddiqui A, Genta R, Berk S. Strongyloidiasis. In: Guerrant R, Walker D, Weller P, editors. Tropical infectious diseases: principles, pathogens, & practice. Philadelphia: Elsevier; 2006. p. 1274–85.

    Google Scholar 

  4. Keiser PB, Nutman TB. Strongyloides stercoralis in the immunocompromised population. Clin Microbiol Rev. 2004;17:208–17.

    Article  PubMed  Google Scholar 

  5. Viney ME, Brown M, Omoding NE, Bailey JW, Gardner MP, Roberts E, Morgan D, Elliott AM, Whitworth JA. Why does HIV infection not lead to disseminated strongyloidiasis? J Infect Dis. 2004;190:2175–80.

    Article  PubMed  Google Scholar 

  6. Karp CL, Auwaerter PG. Coinfection with HIV and tropical infectious diseases II. Helminthic, fungal, bacterial, and viral pathogens. Clin Infect Dis. 2007;45:1214–20.

    Article  PubMed  Google Scholar 

  7. Taylor C, Subbarao V, Gayed S, Ustianowski A. Immune reconstitution syndrome to Strongyloides stercoralis infection. AIDS. 2007;21:649–50.

    Article  PubMed  Google Scholar 

  8. Kim A, Lupatkin H. Strongyloides stercoralis infection as a manifestation of immune restoration syndrome. Clin Infect Dis. 2004;39:439–40.

    Article  PubMed  Google Scholar 

  9. Lanzafame M, Faggian F, Lattuada E, Antolini D, Vento S. Strongyloidiasis in an HIV-1-infected patient after highly active antiretroviral therapy-induced immune restoration. J Infect Dis. 2005;191:1027.

    Article  PubMed  Google Scholar 

  10. Siddiqui AA, Berk SL. Diagnosis of Strongyloides stercoralis infection. Clin Infect Dis. 2001;33:1040–7.

    Article  CAS  PubMed  Google Scholar 

  11. Sato Y, Kobayashi J, Toma H, Shiroma Y. Efficacy of stool examination for detection of Strongyloides infection. Am J Trop Med Hyg. 1995;53:248–50.

    CAS  PubMed  Google Scholar 

  12. Keystone JS. Can one afford not to screen for parasites in high-risk immigrant populations? Clin Infect Dis. 2007;45:1316–8.

    Article  CAS  PubMed  Google Scholar 

  13. Loutfy M, Wilson M, Keystone J, Kain K. Serology and eosinophil count in the diagnosis and management of strongyloidiasis in a non-endemic area. Am J Trop Med Hyg. 2002;66:749–52.

    PubMed  Google Scholar 

  14. Speare R, Durrheim D. Strongyloides serology–useful for diagnosis and management of strongyloidiasis in rural indigenous populations, but important gaps in knowledge remain. Rural Remote Health. 2004;4:264.

    CAS  PubMed  Google Scholar 

  15. Nuesch R, Zimmerli L, Stockli R, Gyr N, Christoph Hatz F. Imported strongyloidosis: a longitudinal analysis of 31 cases. J Travel Med. 2005;12:80–4.

    Article  PubMed  Google Scholar 

  16. Karunajeewa H, Kelly H, Leslie D, Leydon J, Saykao P, Biggs B. Parasite-specific IgG response and peripheral blood eosinophil count following albendazole treatment for presumed chronic strongyloidiasis. J Travel Med. 2006;13:84–91.

    Article  PubMed  Google Scholar 

  17. AIDS study group (GESIDA) and National AIDS Plan Expert Committee: Treatment of opportunistic infections in adolescent and adult patients infected with the human immunodeficiency virus during the era of highly active antiretroviral therapy. Enferm infecc microbiol clin. Spain, 2008, vol 26, pp 356–379.

  18. Martin Sanchez AM, Hernandez Garcia A, Gonzalez Fernandez M, Afonso Rodriguez O, Hernandez Cabrera M, Perez Arellano JL. Parasitosis intestinales en poblacion inmigrante subsahariana asintomatica. Gran canaria 2000. Rev Clin Esp. 2004;204:14–7.

    CAS  PubMed  Google Scholar 

  19. Assefa S, Erko B, Medhin G, Assefa Z, Shimelis T. Intestinal parasitic infections in relation to HIV/AIDS status, diarrhea and CD4 T-cell count. BMC Infect Dis. 2009;9:155.

    Article  PubMed  Google Scholar 

  20. Feitosa G, Bandeira AC, Sampaio DP, Badaro R, Brites C. High prevalence of giardiasis and stronglyloidiasis among HIV-infected patients in Bahia, Brazil. Braz J Infect Dis. 2001;5:339–44.

    Article  CAS  PubMed  Google Scholar 

  21. Getaneh A, Medhin G, Shimelis T. Cryptosporidium and Strongyloides stercoralis infections among people with and without HIV infection and efficiency of diagnostic methods for Strongyloides in Yirgalem Hospital, southern Ethiopia. BMC Res Notes. 2010;3:90.

    Article  PubMed  Google Scholar 

  22. Hailemariam G, Kassu A, Abebe G, Abate E, Damte D, Mekonnen E, Ota F. Intestinal parasitic infections in HIV/AIDS and HIV seronegative individuals in a teaching hospital, Ethiopia. Jpn J Infect Dis. 2004;57:41–3.

    PubMed  Google Scholar 

  23. Wiwanitkit V. Intestinal parasitic infections in Thai HIV-infected patients with different immunity status. BMC Gastroenterol. 2001;1:3.

    Article  CAS  PubMed  Google Scholar 

  24. Pinlaor S, Mootsikapun P, Pinlaor P, Pipitgool V, Tuangnadee R. Detection of opportunistic and non-opportunistic intestinal parasites and liver flukes in HIV-positive and HIV-negative subjects. Southeast Asian J Trop Med Public Health. 2005;36:841–5.

    PubMed  Google Scholar 

  25. Kaminsky RG, Soto RJ, Campa A, Baum MK. Intestinal parasitic infections and eosinophilia in an human immunedeficiency virus positive population in Honduras. Mem Inst Oswaldo Cruz. 2004;99:773–8.

    Article  PubMed  Google Scholar 

  26. Walson JL, Stewart BT, Sangare L, Mbogo LW, Otieno PA, Piper BK, Richardson BA, John-Stewart G. Prevalence and correlates of helminth co-infection in kenyan HIV-1 infected adults. PLoS Negl Trop Dis. 2010;4:e644.

    Article  PubMed  Google Scholar 

  27. Bachur TP, Vale JM, Coelho IC, Queiroz TR, Chaves Cde S. Enteric parasitic infections in HIV/AIDS patients before and after the highly active antiretroviral therapy. Braz J Infect Dis. 2008;12:115–22.

    Article  PubMed  Google Scholar 

  28. Sarner L, Fakoya AO, Tawana C, Allen E, Copas AJ, Chiodini PL, Fenton KA. The utility of screening for parasitic infections in HIV-1-infected Africans with eosinophilia in London. Int J STD AIDS. 2007;18:626–9.

    Article  PubMed  Google Scholar 

  29. Hochberg NS, Moro RN, Sheth AN, Montgomery SP, Steurer F, McAuliffe IT, Wang YF, Armstrong W, Rivera HN, Lennox JL, Franco-Paredes C. High prevalence of persistent parasitic infections in foreign-born, HIV-infected persons in the United States. PLoS Negl Trop Dis. 2011;5:e1034.

    Article  PubMed  Google Scholar 

  30. Martín-Rabadán P, Martínez-Ruiz R, Cuadros J, Cañavate C. El laboratorio de microbiología ante las enfermedades parasitarias importadas. Enferm Infecc Microbiol Clin. 2010;28:719–25.

    Article  PubMed  Google Scholar 

  31. Gonzaga HT, Ribeiro VS, Feliciano ND, Manhani MN, Silva DA, Ueta MT, Costa-Cruz JM. IgG avidity in differential serodiagnosis of human strongyloidiasis active infection. Immunol Lett. 2011;139:87–92.

    Article  CAS  PubMed  Google Scholar 

  32. Cagigi A, Nilsson A, Pensieroso S, Chiodi F. Dysfunctional B-cell responses during HIV-1 infection: implication for influenza vaccination and highly active antiretroviral therapy. Lancet Infect Dis. 2010;10:499–503.

    Article  PubMed  Google Scholar 

  33. Schaffel R, Nucci M, Carvalho E, Braga M, Almeida L, Portugal R, Pulcheri W. The value of an immunoenzymatic test (enzyme-linked immunosorbent assay) for the diagnosis of strongyloidiasis in patients immunosuppressed by hematologic malignancies. Am J Trop Med Hyg. 2001;65:346–50.

    CAS  PubMed  Google Scholar 

  34. Santiago M, Leitão B. Prevention of Strongyloides hyperinfection syndrome: a rheumatological point of view. Eur J Intern Med. 2009;20:744–8.

    Article  CAS  PubMed  Google Scholar 

  35. Roxby AC, Gottlieb GS, Limaye AP. Strongyloidiasis in transplant patients. Clin Infect Dis. 2009;49:1411–23.

    Article  PubMed  Google Scholar 

  36. Kotton CN, Lattes R. Practice AIDCo: parasitic infections in solid organ transplant recipients. Am J Transplant. 2009;9(Suppl 4):S234–51.

    Article  PubMed  Google Scholar 

  37. Muennig P, Pallin D, Challah C, Khan K. The cost-effectiveness of ivermectin vs. Albendazole in the presumptive treatment of strongyloidiasis in immigrants to the United States. Epidemiol Infect. 2004;132:1055–63.

    Article  CAS  PubMed  Google Scholar 

  38. Biggs BA, Caruana S, Mihrshahi S, Jolley D, Leydon J, Chea L, Nuon S. Management of chronic strongyloidiasis in immigrants and refugees: is serologic testing useful? Am J Trop Med Hyg. 2009;80:788–91.

    PubMed  Google Scholar 

  39. Kobayashi J, Sato Y, Toma H, Takara M, Shiroma Y. Application of enzyme immunoassay for postchemotherapy evaluation of human strongyloidiasis. Diagn Microbiol Infect Dis. 1994;18:19–23.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This study was performed during the Río Hortega Research Educational Contract from the Instituto de Salud Carlos III to Jara Llenas-García.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jara Llenas-García.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Llenas-García, J., Fiorante, S., Salto, E. et al. Should We Look for Strongyloides Stercoralis in Foreign-Born HIV-Infected Persons?. J Immigrant Minority Health 15, 796–802 (2013). https://doi.org/10.1007/s10903-012-9756-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10903-012-9756-6

Keywords

Navigation